Multiplex ligation-dependent probe amplification: A diagnostic tool for simultaneous identification of different genetic markers in glial tumors

Journal of Molecular Diagnostics

Volumn 8, Issue 4, 2006, Pages 433-443

  Jeuken, Judith W M ^a   Comelissen, Sandra ^a   Boots Sprenger, Sandra ^a   Gijsen, Sabine ^a   Wesseling, Pieter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCENT DYE; MOLECULAR MARKER; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TISSUE; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC MARKER; GLIOMA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR PROBE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 33745407500     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.060012     Document Type: Article

References (38)

1. Caimcross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein D, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998, 90:1473-1479
2. Schmid JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000, 18:636-645
3. Cairncross JG: Aggressive oligodendroglioma: a chemosensitive tumor. Recent Results Cancer Res 1994, 135:127-133
4. Kyritsis AP, Yung WKA, Bruner J, Gealson M, Levin VA: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993, 32:365-371
5. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003, 63:1602-1607
6. Smith JS, Perry A, Borell TJ, Lee HK, Fallon JO, Hosek SM, Kimmel D, Yates A, Burger PC, Schelthauer BW, Jenkins RB: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, mixed oligoastrocytomas. J Clin Oncol 2000, 18:636-645
7. van den Bent MJ. Looijenga LHJ, Langberg K, Dinjens W, Gravenland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM: Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. Cancer 2003, 97:1276-1284
8. luchi T, Namba H, Iwadate Y, Shishikura T, Kageyama H, Nakamura Y, Ohira M, Yamaura A, Osato K, Sakiyama S, Nakagawara A: Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors. Gen Chromosom Cancer 2002, 35:170-175
9. Bauman GS, Ino Y, Ueki K, Zlatescu MC, Fisher BJ, Macdonald DR, Stitt L, Louis DN, Cairncross JG: Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 2000, 48:825-830
10. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Sternmer- Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN: Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 2001, 7:839-845
11. Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A: Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997, 56:1098-1104
12. Wolter M, Reifenberger J, Blaschke B, Ichimura K, Schmidt EE, Collins VP, Reifenberger G: Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p161NK4a). p14ARF, and CDKN2B (MTS2, p151NK4b) tumor suppressor genes. J Neuropathol Exp Neurol 2001, 60:1170-1180
13. Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H: Phenotype versus genotype correlation in oligodendrogliornas and low-grade diffuse astrocytomas. Acta Neuropathol (Berl) 2002, 103:267-275
14. von Deimling A. Firnmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, Jahnke R, Kaskel P, Duerr E, Koopmann J, Maintz D, Steinbeck S, Wick W, Platten M, Muller DJ, Przkora R, Waha A, Blumcke B, Wellenreuther R, Meyer-Puttlitz B, Schmidt O, Mollenhauer J, Poustka. A, Stangl AP, Lenartz D, von Ammon K, Henson JW, Schramm J, Louis DN, Wiestler OD: Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 2000, 56:544-558
15. Reifenberger G, Kros JM, Burger PC, Louis DN, Collins VP: Oligodendroglial tumors and mixed gliomas. WHO classification. Tumours of the Nervous System. Edited by Kleihues P, Cavenee WK. Lyon, International Agency for Research on Cancer (IARC) Press, 1999, pp 55-70
16. Reifenberger G, Louis DN: Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003, 62:111-126
17. Smith JS, Alderete BE, Minn Y, Borell T, Perry A, Mohapatra G, Smith SM, Kimmel D, Fallon JO, Tates A, Feuerstein BG, Burger PC, Scheithauer BW: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999, 18:4144-4152
18. Hatanpaa KJ. Burger PC, Eshleman JR, Murphy KM, Berg KD: Molecular diagnosis of oligodendroglioma in paraffin sections. Lab Invest 2003, 83:419-428
19. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, Gray JW, Jensen RH: Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000, 60:5405-5409
20. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape KD: Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 2001, 158:1253-1262
21. Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G: Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathol 2004, 14:121-130
22. McLendon RE, Herndon JE, West B, Reardon D, Wiltshire R, Rasheed BK, Quinn J, Friedman HS, Friedman AH, Bigner DD: Survival analysis of presumptive prognostic markers among oligodendrogliomas. Cancer 2005, 104:1693-1699
23. Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M, Mokhtari K, Sanson M, Lejeune J, Aurias A, Delattre O, Delattre JY: Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 2005, 58:483-487
24. Jeuken JWM, Boots-Sprenger SHE, Wesseling P: Chromosomal imbalances in oligodendroglial tumors as detected by comparative genomic hybridization (CGH). Genomic and Molecular Neuro-Oncology. Edited by Zhang W, Fuller GN. Boston, Jones and Bartlett Publishers, 2004, pp 185-198
25. Jeuken JWM, Sprenger SHE, Wesseling P, Macville MVE, von Deimling A, Teepen HLJM, van Overbeeke JJ, Boerman RH: Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol 1999, 58:606-612
26. Jeuken JWM, Sprenger SHE, Boerman RH, von Deimling A, Teepen HLJM, van Overbeeke JJ, Wesseling P: Subtyping of oligo-astrocytic tumours by comparative genomic hybridisation. J Pathol 2001, 194:81-87
27. Jeuken JWM, Sprenger SHE, Vermeer H, Kappelle AC, Boerman RH, Wesseling P: Chromosomal imbalances in primary oligodendroglial tumors and their recurrences; clues for malignant progression as detected by CGH. J Neurosurg 2002, 96:559-564
28. Jeuken JWM, Sprenger SHE, Wesseling P: Comparative genomic hybridization: practical guidelines. Diagn Mol Pathol 2002, 11:193-203
29. Cowell JK, Barnett GH, Nowak NJ: Characterization of the 1p/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa). J Neuropathol Exp Neurol 2004, 63:151-158
30. Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB: Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Gene Chromosom Cancer 2005, 42:68-77
31. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Res 2002, 30:e57
32. Kleihues P, Cavenee WK: Pathology and genetics. Tumours of the nervous system. World Health Organization Classification of Tumours. Lyon, France, International Agency for Research on Cancer (IARC) Press, 2000
33. Miller SA, Dykes DD, Polsky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215
34. van Dijk MC, Rombout PD, Boots-Sprenger SH, Straatman H, Bernsen MR, Ruiter DJ, Jeuken JW: Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol 2005, 14:9-16
35. Jeuken JWM, Sprenger SHE, Wesseling P, Bernsen HJJA, Suijkerbuijk RF, Roelofs F, Macville MVE, Gilhuis HJ, van Overbeeke JJ, Boerman RH: Xenografts genetically reflect glioblastoma biopsies: characterization of 11 glioblastorna xenograft lines by comparative genomic hybridization. J Neurosurg 1999, 92:652-658
36. Jeuken JWM, Boots-Sprenger SHE, Wesseling P: Multiplex ligation dependent probe amplification for the detection of 1p and 19q loss in oligodendroglial tumors. Brain Pathol 2005, 15:364-365
37. Natté R, van Eijk R, Eilers P, Cleton-Jansen AM, Costing J, Kouwehove M, Kros JM, van Duinen S: Multiplex ligation dependent probe amplification for the detection of 1p and 19q loss in oligodendroglial tumors. Brain Pathol 2005, 15:192-197
38. Jeuken JW, von Deimling A, Wesseling P: Molecular pathogenesis of oligodendroglial tumors. J Neurooncol 2004. 70:161-181